China Biotech CEO Interview with Hua Medicine’s Li Chen

Hua Medicine’s founder and CEO Li Chen discusses with host Brian Yang about its new product launch for dorzagliatin, glucokinase activator for type 2 diabetes in China, partnership with Bayer, and plans to get reimbursed through National Reimbursement Drug List. https://scrip.pharmaintelligence.informa.com/SC148981/Hua-Medicines-Chen-On-Product-Launch-Bayer-Partnership-And-Reimbursement